|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A calmodulin (CaM) binding 'IQ' domain on the L-type Ca2+ channel (LTCC) C terminus and calmodulin kinase II (CaMK) both signal increases in LTCC opening probability (Po) by shifting LTCCs into a gating mode (mode 2) with long openings through a process called facilitation. However, the mechanism whereby CaMK and the IQ domain are targeted to LTCCs is unknown. Endogenous CaMK is targeted to LTCCs in excised cell membrane patches because LTCC Po increased significantly in CaM-enriched (20 µM) bath solution and this effect was prevented by a specific CaMK inhibitory peptide, but not by an inactive control peptide. Pre-exposure of myocytes to the cytoskeletal disrupting agents nocodazole (microtubule specific) or cytochalasin D (microfilament specific) prevented the effects of CaM-dependent increases in Po of LTCCs in excised membrane patches. Neither cytochalasin D nor nocodazole altered the distribution of LTCC gating modes under basal conditions in on-cell mode or excised cell membrane patches, but each of these agents occluded the response of LTCCs to exogenous, constitutively active CaMK and to an IQ-mimetic peptide (IQmp). Cytochalasin D and nocodazole pretreatment also prevented LTCC facilitation that followed a cell membrane depolarizing prepulse. In contrast, cytochalasin D and nocodazole did not affect the increase in LTCC Po or prevent the shift to mode 2 gating in response to protein kinase A, indicating that cytoskeletal disruption specifically prevents prepulse, CaMK and IQ-dependent LTCC facilitation.
This article has been cited by other articles:
![]() |
Y. Wang, S. Tandan, J. Cheng, C. Yang, L. Nguyen, J. Sugianto, J. L. Johnstone, Y. Sun, and J. A. Hill Ca2+/Calmodulin-dependent Protein Kinase II-dependent Remodeling of Ca2+ Current in Pressure Overload Heart Failure J. Biol. Chem., September 12, 2008; 283(37): 25524 - 25532. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Couchonnal and M. E. Anderson The Role of Calmodulin Kinase II in Myocardial Physiology and Disease Physiology, June 1, 2008; 23(3): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Anderson Multiple downstream proarrhythmic targets for calmodulin kinase II: Moving beyond an ion channel-centric focus Cardiovasc Res, March 1, 2007; 73(4): 657 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-S. Lee, R. Karl, S. Moosmang, P. Lenhardt, N. Klugbauer, F. Hofmann, T. Kleppisch, and A. Welling Calmodulin Kinase II Is Involved in Voltage-dependent Facilitation of the L-type Cav1.2 Calcium Channel: IDENTIFICATION OF THE PHOSPHORYLATION SITES J. Biol. Chem., September 1, 2006; 281(35): 25560 - 25567. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo and H. J. Duff Calmodulin kinase II accelerates L-type Ca2+ current recovery from inactivation and compensates for the direct inhibitory effect of [Ca2+]i in rat ventricular myocytes J. Physiol., July 15, 2006; 574(2): 509 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Anderson The Fire From Within: The Biggest Ca2+ Channel Erupts and Dribbles Circ. Res., December 9, 2005; 97(12): 1213 - 1215. [Full Text] [PDF] |
||||
![]() |
Z.-Z. Wu, S.-R. Chen, and H.-L. Pan Transient Receptor Potential Vanilloid Type 1 Activation Down-regulates Voltage-gated Calcium Channels through Calcium-dependent Calcineurin in Sensory Neurons J. Biol. Chem., May 6, 2005; 280(18): 18142 - 18151. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, J. T. Kimbrough, R. J. Colbran, and M. E. Anderson Calmodulin kinase is functionally targeted to the action potential plateau for regulation of L-type Ca2+ current in rabbit cardiomyocytes J. Physiol., January 1, 2004; 554(1): 145 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Welsby, H. Wang, J. T. Wolfe, R. J. Colbran, M. L. Johnson, and P. Q. Barrett A Mechanism for the Direct Regulation of T-Type Calcium Channels by Ca2+/Calmodulin-Dependent Kinase II J. Neurosci., November 5, 2003; 23(31): 10116 - 10121. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Erxleben, C. Gomez-Alegria, T. Darden, Y. Mori, L. Birnbaumer, and D. L. Armstrong Modulation of cardiac CaV1.2 channels by dihydropyridine and phosphatase inhibitor requires Ser-1142 in the domain III pore loop PNAS, March 4, 2003; 100(5): 2929 - 2934. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |